FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia ; volume:16 ; number:1 ; day:11 ; month:2 ; year:2023 ; pages:1-22 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (11.2.2023), 1-22, 12.2023
- Urheber
-
Zhu, Xiao-Na
Wei, Yu-Sheng
Yang, Qian
Liu, Hao-Ran
Zhi, Zhe
Zhu, Di
Xia, Li
Hong, Deng-Li
Yu, Yun
Chen, Guo-Qiang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01400-0
- URN
-
urn:nbn:de:101:1-2023041509170078884344
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhu, Xiao-Na
- Wei, Yu-Sheng
- Yang, Qian
- Liu, Hao-Ran
- Zhi, Zhe
- Zhu, Di
- Xia, Li
- Hong, Deng-Li
- Yu, Yun
- Chen, Guo-Qiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Using genome editing to model MLL rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Using genome editing to model MLL rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes
Study on the age-period-cohort effects of cognitive abilities among older Chinese adults based on the cognitive reserve hypothesis
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileus
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia